Reporting adverse reactions

Please report any adverse reactions to our products to the Daiichi Sankyo Contact Center at 1-877-4 DS-PROD (1-877-437-7763). Or to report negative side effects of prescription drugs to the FDA visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Scientific breakthroughs helping patients

DSI’s comprehensive portfolio, including our cardiovascular and metabolic therapies, offers innovative treatments for a wide range of diseases.

Compassion for patients

Patient Assistance Program

Compassion for patients.

A commitment to ensuring that our medicines are available to those who need them most is just as important as our commitment to developing innovative treatments. We have helped thousands of Americans gain access to our hypertension and cholesterol medications through our patient assistance program.

The Daiichi Sankyo Open Care Program offers assistance to qualified individuals who demonstrate medical and financial need. The program provides free products to those who are prescribed Daiichi Sankyo products and are under- and uninsured, as well as unable to identify alternative payment sources. For more information call 1-866-268-7327.

Click here to download a Daiichi Sankyo Open Care Program patient assistance application

Daiichi Sankyo products covered by the Open Care Program:

AZOR® (amlodipine/olmesartan medoxomil)
See full Prescribing Information including Boxed WARNING regarding Fetal Toxicity.

BENICAR® (olmesartan medoxomil)
See full Prescribing Information including Boxed WARNING regarding Fetal Toxicity.

BENICAR HCT® (olmesartan medoxomil/hydrocholorothiazide) 
See full Prescribing Information including Boxed WARNING regarding Fetal Toxicity.

TRIBENZOR® (olmesartan medoxomil/amlodipine/hydrocholorothiazide)
See full Prescribing Information including Boxed WARNING regarding Fetal Toxicity.

WELCHOL® (colesevelam HCL)
See full Prescribing Information.

 

Partnership for Prescription Assistance
Partnership for Prescription Assistance

Daiichi Sankyo, Inc. is also a proud member of Pharmaceutical Research and Manufacturers of America's Partnership for Prescription Assistance (PPA) program. The PPA is a national coalition of pharmaceutical companies, doctors and other health care providers, pharmacists, patient advocates and community groups. PPA helps patients identify potential assistance programs, assess potential eligibility and obtain enrollment forms. Visit www.pparx.org for more information or call 1-888-4PPA-NOW.